Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer

Gene

Volumn 543, Issue 1, 2014, Pages 101-107

  Xie, Kaipeng ^a   Liu, Jibin ^c   Chen, Jiaping ^a   Dong, Jing ^a   Ma, Hongxia ^a   Liu, Yao ^a   Hu, Zhibin ^a,b  

^a Nanjing Medical University   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANTONG TUMOR HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; Methylation; MiR 34a; MiR 34b c

Indexed keywords

MICRORNA; MICRORNA 34A; MICRORNA 34B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HEPATOCELLULAR CARCINOMA; METHYLATION; MIR-34A; MIR-34B/C;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED;

EID: 84899646114     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.03.059     Document Type: Article

References (46)

1. Alpini G., et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. Journal of Hepatology 2011, 55:1339-1345.
2. Anwar S.L., et al. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. International Journal of Cancer 2013, 133:660-670.
3. Arzumanyan A., Reis H.M., Feitelson M.A. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nature Reviews. Cancer 2013, 13:123-135.
4. Bommer G.T., et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Current Biology 2007, 17:1298-1307.
5. Chang T.C., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell 2007, 26:745-752.
6. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. The New England Journal of Medicine 2005, 353:1768-1771.
7. Chen X., et al. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. International Journal of Cancer 2012, 130:1607-1613.
8. Cheng J., et al. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells. Proteomics 2010, 10:1557-1572.
9. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Research 2007, 67:8433-8438.
10. Corney D.C., et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clinical Cancer Research 2010, 16:1119-1128.
11. Datta J., et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Research 2008, 68:5049-5058.
12. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
13. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31:766-776.
14. Gramantieri L., et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Research 2007, 67:6092-6099.
15. He L., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
16. Heller G., et al. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. Clinical Cancer Research 2012, 18:1619-1629.
17. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death and Differentiation 2010, 17:193-199.
18. Hu Z., et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. The Journal of Clinical Investigation 2008, 118:2600-2608.
19. Hu Z., et al. Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. American Journal of Respiratory and Critical Care Medicine 2011, 183:641-648.
20. Iorio M.V., Croce C.M. MicroRNAs in cancer: small molecules with a huge impact. Journal of Clinical Oncology 2009, 27:5848-5856.
21. Jiang J., et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clinical Cancer Research 2008, 14:419-427.
22. Jiang D.K., et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nature Genetics 2013, 45:72-75.
23. Kalimutho M., et al. Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. British Journal of Cancer 2011, 104:1770-1778.
24. Kim J.K., et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 2013, 57:1055-1067.
25. Kozaki K., Imoto I., Mogi S., Omura K., Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Research 2008, 68:2094-2105.
26. Kubo T., et al. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clinical Cancer Research 2011, 17:4965-4974.
27. Kumaki Y., Oda M., Okano M. QUMA: quantification tool for methylation analysis. Nucleic Acids Research 2008, 36:W170-W175.
28. Landan G., et al. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nature Genetics 2012, 44:1207-1214.
29. Li N., et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Letters 2009, 275:44-53.
30. Lodygin D., et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
31. Lopez-Serra P., Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012, 31:1609-1622.
32. Lujambio A., et al. A microRNA DNA methylation signature for human cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13556-13561.
33. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:9667-9672.
34. Pogribny I.P., Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Letters 2012, 342:223-230.
35. Shen J., et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012, 55:1799-1808.
36. Shen J., et al. Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma. Epigenetics 2012, 7:1230-1237.
37. Suzuki H., et al. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 2010, 31:2066-2073.
38. Tanaka N., et al. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 2012, 76:32-38.
39. Tarasov V., et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6:1586-1593.
40. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
41. Tian Y., Yang W., Song J., Wu Y., Ni B. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Molecular and Cellular Biology 2013, 33:2810-2816.
42. Toyota M., et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Research 2008, 68:4123-4132.
43. Tsai K.W., et al. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. International Journal of Cancer 2011, 129:2600-2610.
44. Vogt M., et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Archiv 2011, 45l8:313-322.
45. Yang J.D., Roberts L.R. Hepatocellular carcinoma: A global view. Nature Reviews. Gastroenterology & Hepatology 2010, 7:448-458.
46. Yang H., et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013, 32:663-669.